News
Stay Up to Date
with the Latest
News.
The science
moves fast
and so do
the stories.
ADDF Financing
Alzheimer’s disease: The Alzheimer’s Drug Discovery Foundation (ADDF) invests $4.2M in GliaPharm to advance its lead program
Innosuisse support
GliaPharm receives support from Innosuisse for a project to develop specific cell therapy to treat neurological diseases in collaboration with Universities of Bern and Lausanne.
HEPIA collaboration
GliaPharm receives grant for collaboration with HEPIA to setup a new 3D culture method using brain organoids from mouse and human-derived cells.
European Congress of Neuropsychopharmacology
GliaPharm to present at the European Congress of Neuropsychopharmacology – Symposium on “Beyond the Neurocentric Paradigm: Targeting Astrocytes and Neuroglial Interactions in CNS Disorders”. September 13th 2020.
LifeSci Symposium
GliaPharm presented at the LifeSci Partners Summer Symposium on August 5th 2020
